Objective: The study sought to describe patient-entered supplemental information on symptomatic adverse events (AEs) in cancer clinical research reported via a National Cancer Institute software system and examine the feasibility of mapping these entries to established terminologies. Materials and Methods: Patients in 3 multicenter trials electronically completed surveys during cancer treatment. Each survey included a prespecified subset of items from the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Upon completion of the survey items, patients could add supplemental symptomatic AE information in a free text box. As patients typed into the box, structured dr...
IMPORTANCE Standard adverse event (AE) reporting in oncology clinical trials has historically relied...
Background: Significant adverse events (AE) during cancer therapy disrupt treatment and escalate to ...
PURPOSE: Adverse event (AE) reporting is essential in clinical trials. Clinician interpretation can...
Purpose—To assess the feasibility of measuring symptomatic adverse events (AEs) in a multicenter cli...
The National Cancer Institute (NCI) is developing a patient-reported version of its Common Terminolo...
Symptomatic adverse events (AEs) are monitored by clinicians as part of all US-based clinical trials...
Symptomatic adverse events (AEs) in cancer trials are currently reported by clinicians using the Nat...
Understanding the potential profile of adverse events associated with cancer treatment is essential ...
The National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria...
Purpose The US National Cancer Institute (NCI) Patient-Reported Outcomes version of the Common Termi...
IMPORTANCE: In cancer clinical trials, symptomatic adverse events (AEs), such as nausea, are reporte...
Purpose There is increasing interest to use patient-reported outcome (PRO) measures to evaluate symp...
There is growing interest to enhance symptom monitoring during routine cancer care using patient-rep...
Systematic capture of the patient perspective can inform the development of new cancer therapies. Pa...
ImportanceIn cancer clinical trials, symptomatic adverse events (AEs), such as nausea, are reported ...
IMPORTANCE Standard adverse event (AE) reporting in oncology clinical trials has historically relied...
Background: Significant adverse events (AE) during cancer therapy disrupt treatment and escalate to ...
PURPOSE: Adverse event (AE) reporting is essential in clinical trials. Clinician interpretation can...
Purpose—To assess the feasibility of measuring symptomatic adverse events (AEs) in a multicenter cli...
The National Cancer Institute (NCI) is developing a patient-reported version of its Common Terminolo...
Symptomatic adverse events (AEs) are monitored by clinicians as part of all US-based clinical trials...
Symptomatic adverse events (AEs) in cancer trials are currently reported by clinicians using the Nat...
Understanding the potential profile of adverse events associated with cancer treatment is essential ...
The National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria...
Purpose The US National Cancer Institute (NCI) Patient-Reported Outcomes version of the Common Termi...
IMPORTANCE: In cancer clinical trials, symptomatic adverse events (AEs), such as nausea, are reporte...
Purpose There is increasing interest to use patient-reported outcome (PRO) measures to evaluate symp...
There is growing interest to enhance symptom monitoring during routine cancer care using patient-rep...
Systematic capture of the patient perspective can inform the development of new cancer therapies. Pa...
ImportanceIn cancer clinical trials, symptomatic adverse events (AEs), such as nausea, are reported ...
IMPORTANCE Standard adverse event (AE) reporting in oncology clinical trials has historically relied...
Background: Significant adverse events (AE) during cancer therapy disrupt treatment and escalate to ...
PURPOSE: Adverse event (AE) reporting is essential in clinical trials. Clinician interpretation can...